Ryman Healthcare Ltd
F:RH7
Ryman Healthcare Ltd
F:RH7
Price:
1.101
EUR
Market Cap:
€754.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Ryman Healthcare Ltd
F:RH7
|
NZ |
|
L
|
LY Corp
SWB:YOJ
|
JP |
|
Vodacom Group Ltd
F:5VD0
|
ZA |
|
B
|
Barclays PLC
DUS:BCY
|
UK |
|
ARMOUR Residential REIT Inc
F:2AR
|
US |
|
Anoto Group AB
F:XTL1
|
SE |
|
Crane Co
F:T12
|
US |
|
Tharisa PLC
F:7YZ
|
CY |
|
F
|
Fastly Inc
F:2Y7
|
US |
|
O
|
OC Oerlikon Corporation AG Pfaeffikon
XMUN:OBH
|
CH |
|
H
|
Humm Group Ltd
F:F5L
|
AU |
|
Stadio Holdings Ltd
F:0JX
|
ZA |
|
Fujikura Ltd
F:FJK
|
JP |
|
W
|
Waters Corp
XMUN:WAZ
|
US |
|
Next Biometrics Group ASA
F:NT7
|
NO |
|
A
|
Alpha Services and Holdings SA
ATHEX:ALPHA
|
GR |
|
4Front Ventures Corp
OTC:FFNTF
|
US |
Wall St Price Targets
RH7 Price Targets Summary
Ryman Healthcare Ltd
Ryman Healthcare Ltd
Wall Street analysts forecast RH7 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RH7 is 1.822 EUR with a low forecast of 1.585 EUR and a high forecast of 2.275 EUR.
Lowest Forecast
Price Target
1.585
EUR
44% Upside
Average Forecast
Price Target
1.822
EUR
65% Upside
Highest Forecast
Price Target
2.275
EUR
107% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RH7's stock price target?
Price Target
1.822
EUR
1.822
EUR
According to Wall Street analysts, the average 1-year price target for RH7 is 1.822 EUR with a low forecast of 1.585 EUR and a high forecast of 2.275 EUR.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
